The future of anti-aging will be a growing set of interventions aimed at different parts of biology. Amity exists to make that future usable: one evolving strategy, built around one person.
↓ The ideaAging emerges from many interacting biological processes. The useful interventions will not all come from one company, one specialty, or one generation of science. Some will improve existing risk factors. Some will target mechanisms of aging directly. Some have not been invented yet.
The goal is not to pick one winner. The goal is to know what belongs together.
Imagine anti-aging medicine with dozens of meaningful interventions. Each has different evidence, tradeoffs, targets, timing, and interactions. The bottleneck stops being access to information. It becomes coordination.
The system starts with the person. Which parts of aging appear most relevant? Which interventions are actually worth considering? What should be combined, avoided, delayed, or revisited later?
Every new therapy, diagnostic, or biological insight should become another tool the system can understand and place in context.
Use current evidence, existing interventions, and a person’s own biology to make anti-aging less generic.
New science should expand the strategy without forcing each person to rebuild it from scratch.
Drugs, diagnostics, therapies, clinicians, and future technologies become parts of one continuously updated plan.
Aging should be acted on before disease becomes the only thing medicine can see.
Personalization should change decisions, not just decorate a dashboard.
Interventions should be coordinated instead of sold as isolated stacks.
The plan should keep changing as the person and the science change.
Not one cure. Not one stack. Not one snapshot of biological age. A living strategy that can keep incorporating better ways to act on aging for decades.
Join early access →